Cargando…
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations
BACKGROUND: Intravenous methylprednisolone (IV-MP) is an established treatment for multiple sclerosis (MS) relapses, accompanied by rapid, though transient reduction of gadolinium enhancing (Gd+) lesions on brain MRI. Intermittent IV-MP, alone or with immunomodulators, has been suggested but insuffi...
Autores principales: | Then Bergh, Florian, Kümpfel, Tania, Schumann, Erina, Held, Ulrike, Schwan, Michaela, Blazevic, Mirjana, Wismüller, Axel, Holsboer, Florian, Yassouridis, Alexander, Uhr, Manfred, Weber, Frank, Daumer, Martin, Trenkwalder, Claudia, Auer, Dorothee P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1501038/ https://www.ncbi.nlm.nih.gov/pubmed/16719908 http://dx.doi.org/10.1186/1471-2377-6-19 |
Ejemplares similares
-
FKBP5 Genotype-Dependent DNA Methylation and mRNA Regulation After Psychosocial Stress in Remitted Depression and Healthy Controls
por: Höhne, Nina, et al.
Publicado: (2015) -
Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study
por: Schwartzbach, Caryl J., et al.
Publicado: (2016) -
Unstable Prefrontal Response to Emotional Conflict and Activation of Lower Limbic Structures and Brainstem in Remitted Panic Disorder
por: Chechko, Natalya, et al.
Publicado: (2009) -
Sleep disturbances in highly stress reactive mice: Modeling endophenotypes of major depression
por: Fenzl, Thomas, et al.
Publicado: (2011) -
Recurrent suicide attempts affect normalization of HPA axis dysregulation after recovery from major depression
por: Hennings, Johannes M., et al.
Publicado: (2022)